7-150958103-A-G

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 3P and 4B. PP2PP3_ModerateBS2

The NM_000238.4(KCNH2):​c.872T>C​(p.Met291Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000505 in 1,288,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M291R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000055 ( 0 hom. )

Consequence

KCNH2
NM_000238.4 missense

Scores

7
3
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4O:1

Conservation

PhyloP100: 4.34

Publications

3 publications found
Variant links:
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]
KCNH2 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • short QT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • short QT syndrome type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 158 curated pathogenic missense variants (we use a threshold of 10). The gene has 38 curated benign missense variants. Gene score misZ: 3.3724 (above the threshold of 3.09). Trascript score misZ: 2.4846 (below the threshold of 3.09). GenCC associations: The gene is linked to long QT syndrome 2, Brugada syndrome, short QT syndrome type 1, short QT syndrome, long QT syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.846
BS2
High AC in GnomAdExome4 at 62 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNH2NM_000238.4 linkc.872T>C p.Met291Thr missense_variant Exon 4 of 15 ENST00000262186.10 NP_000229.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNH2ENST00000262186.10 linkc.872T>C p.Met291Thr missense_variant Exon 4 of 15 1 NM_000238.4 ENSP00000262186.5

Frequencies

GnomAD3 genomes
AF:
0.0000198
AC:
3
AN:
151790
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000442
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000546
AC:
62
AN:
1136414
Hom.:
0
Cov.:
31
AF XY:
0.0000479
AC XY:
26
AN XY:
542860
show subpopulations
African (AFR)
AF:
0.0000435
AC:
1
AN:
22988
American (AMR)
AF:
0.00
AC:
0
AN:
8762
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15234
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26416
South Asian (SAS)
AF:
0.0000293
AC:
1
AN:
34146
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
25254
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3084
European-Non Finnish (NFE)
AF:
0.0000618
AC:
59
AN:
954102
Other (OTH)
AF:
0.0000215
AC:
1
AN:
46428
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000198
AC:
3
AN:
151790
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74122
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41300
American (AMR)
AF:
0.00
AC:
0
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10550
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.0000442
AC:
3
AN:
67936
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000340

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Long QT syndrome Uncertain:1
Dec 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 291 of the KCNH2 protein (p.Met291Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with sudden arrhythmic death syndrome (PMID: 19716085, 28449774). ClinVar contains an entry for this variant (Variation ID: 67537). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Cardiovascular phenotype Uncertain:1
Mar 06, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.M291T variant (also known as c.872T>C), located in coding exon 4 of the KCNH2 gene, results from a T to C substitution at nucleotide position 872. The methionine at codon 291 is replaced by threonine, an amino acid with similar properties. This alteration has been reported in a long QT syndrome genetic testing cohort and a sudden arrhythmic death syndrome cohort; however, clinical details were limited in both cohorts (Kapplinger JD et al. Heart Rhythm, 2009 Sep;6:1297-303; Lahrouchi N et al. J Am Coll Cardiol, 2017 May;69:2134-2145). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Short QT syndrome type 1;C3150943:Long QT syndrome 2 Uncertain:1
Sep 23, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital long QT syndrome Other:1
-
Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.49
CardioboostArm
Uncertain
0.15
BayesDel_addAF
Pathogenic
0.40
D
BayesDel_noAF
Pathogenic
0.33
CADD
Uncertain
24
DANN
Benign
0.89
DEOGEN2
Benign
0.38
T;T
Eigen
Benign
0.063
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.62
T;T
M_CAP
Pathogenic
0.81
D
MetaRNN
Pathogenic
0.85
D;D
MetaSVM
Pathogenic
0.90
D
MutationAssessor
Benign
1.3
L;.
PhyloP100
4.3
PrimateAI
Pathogenic
0.98
D
PROVEAN
Benign
-1.8
N;.
REVEL
Pathogenic
0.74
Sift
Benign
0.17
T;.
Sift4G
Benign
0.39
T;T
Polyphen
0.79
P;.
Vest4
0.67
MutPred
0.70
Gain of phosphorylation at M291 (P = 0.0198);.;
MVP
0.99
MPC
1.2
ClinPred
0.39
T
GERP RS
3.8
Varity_R
0.25
gMVP
0.65
Mutation Taster
=10/90
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199472881; hg19: chr7-150655191; API